Podcast Episodes

Back to Search
HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options

Episode 212

In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the personalized care of patients with H…

6 months ago

Short Long
View Episode
Key Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma
Key Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma

Episode 211

In this episode, Dr Christopher Flowers and Dr John Allan discuss their experience with the use of CD20xCD3 bispecific antibodies in the treatment of…

7 months ago

Short Long
View Episode
Pancreatic Cancer Progress: Expert Insights on Treatment Choices and Collaborating with Patients
Pancreatic Cancer Progress: Expert Insights on Treatment Choices and Collaborating with Patients

Episode 210

Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O’Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic canc…

7 months, 1 week ago

Short Long
View Episode
Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma
Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma

Episode 209

In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myelo…

7 months, 1 week ago

Short Long
View Episode
CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer: Experts Answer Your Questions
CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer: Experts Answer Your Questions

Episode 206

In this episode, Drs William J. Gradishar, Heather McArthur, and Joanne Mortimer address audience questions from a recent live event on the use of CD…

7 months, 2 weeks ago

Short Long
View Episode
Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas
Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas

Episode 208

In this episode, Dr. Daniel Morgensztern and Dr. Jonathan Strosberg discuss the emerging role of DLL3-targeted agents in the management of extrapulmo…

7 months, 4 weeks ago

Short Long
View Episode
Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective

Episode 207

In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging …

8 months ago

Short Long
View Episode
Key Advances in Lymphomas and Acute Lymphocytic Leukemia From EHA and ICML 2025
Key Advances in Lymphomas and Acute Lymphocytic Leukemia From EHA and ICML 2025

Episode 205

In this podcast, Max S. Topp, MD, and Pier Luigi Zinzani, MD, PhD, explore the current and future implications of some of their top choices of studie…

8 months, 2 weeks ago

Short Long
View Episode
Experts Discuss Key Studies in Breast Cancer: Independent Conference Coverage of the 2025 ASCO Annual Meeting
Experts Discuss Key Studies in Breast Cancer: Independent Conference Coverage of the 2025 ASCO Annual Meeting

Episode 204

In this episode, Kevin Kalinsky, MD, MS, FASCO, and Sara M. Tolaney, MD, MPH, discuss the most clinically relevant data in breast cancer presented at…

8 months, 2 weeks ago

Short Long
View Episode
Takeaways From a Large Educational Program on Available and Emerging Treatment Options for HER2-Positive mBC
Takeaways From a Large Educational Program on Available and Emerging Treatment Options for HER2-Positive mBC

Episode 203

In this episode, listen to Laura M. Spring, MD; and Shipra Gandhi, MD, MS, share their takeaways from a large educational program on available and em…

8 months, 3 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us